Yapei

The supplied subject is 雅培, with the disambiguating alias 雅培(洗护), indicating a personal-care or wash-and-care brand rather than the internationally known Abbott Laboratories healthcare company. No reliable Wikipedia article, official website, corporate profile, product catalogue, ownership record, founding information, headquarters, market footprint, or independently verifiable history for this specific brand was supplied. The available reference material concerns Abbott Laboratories, a separate United States healthcare corporation, and therefore cannot safely be used to populate this dossier. In particular, the supplied information about medical products, nutrition products, acquisitions, stock listing, executives, and infant-formula recalls belongs to Abbott Laboratories and is excluded here to avoid conflating two different entities. The brand’s exact legal owner, product range, launch date, distribution geography, and current operating status remain unresolved. Additional verification through trademark records, packaging, retailer listings, an official corporate account, or a reliable business-registration source is required before a substantive encyclopedia entry can be written.

No reliable historical record for the specific 雅培(洗护) brand was provided. The supplied references predominantly describe Abbott Laboratories, the United States healthcare company, which is a distinct subject and should not be merged into this entry. As a result, the brand’s origin, ownership, registration, product development, distribution, marketing history, and present status cannot be established without further evidence. The alias suggests a wash-and-care or personal-care classification, but it does not by itself establish a corporate relationship with any similarly named organization. Verification should prioritize primary materials identifying the trademark owner and product manufacturer, together with dated packaging or regulatory records and reliable retail or trade coverage.

• 2022

  Abbott China initiates a voluntary recall of infant nutrition products

  Abbott China initiated a voluntary recall of the Similac HMFortifi specialized medical-use infant nutrition supplement that had been exported to China, following reports involving infants who consumed certain Abbott-produced formula products and an FDA investigation.

  Source

• 2021

  Abbott trading company fined over infant formula quality issue

  The article reports that Abbott Trading (Shanghai) Co., Ltd. was fined and had amounts confiscated in connection with infant formula in which vanillin was detected. The supplied text does not specify the penalty date or amount.

  Source

• 2021

  Abbott completed recovery of affected formula batch from the market

  Abbott China said it had completed recovery of all remaining products from the affected batch of Abbott Similac platinum infant formula stage 1. The company said the batch had tested positive for trace vanillin and apologized for the inconvenience to consumers.

  Source

Read more

• Unconfirmed

  Abbott plans to spin off its nutrition business[4]雅培计划分拆营养业务cfi.net.cn

  Abbott plans to separate its nutrition business into an independent company; the article says the separation will be tax-free and existing shareholders will hold shares in both companies.

• Unconfirmed

  Reported2022.02.20

  Abbott China initiates a voluntary recall of infant nutrition products[1]Abbott China initiates a voluntary recall of infant nutrition productsworkercn.cn

  Abbott China initiated a voluntary recall of the Similac HMFortifi specialized medical-use infant nutrition supplement that had been exported to China, following reports involving infants who consumed certain Abbott-produced formula products and an FDA investigation.

• Unconfirmed

  Reported2021.06.03

  Abbott trading company fined over infant formula quality issue[2]Abbott trading company fined over infant formula quality issuefinance.sina.com.cn

  The article reports that Abbott Trading (Shanghai) Co., Ltd. was fined and had amounts confiscated in connection with infant formula in which vanillin was detected. The supplied text does not specify the penalty date or amount.

• Unconfirmed

  Reported2021.05.16

  Abbott completed recovery of affected formula batch from the market[3]Abbott completed recovery of affected formula batch from the marketfinance.sina.com.cn

  Abbott China said it had completed recovery of all remaining products from the affected batch of Abbott Similac platinum infant formula stage 1. The company said the batch had tested positive for trace vanillin and apologized for the inconvenience to consumers.

• 2021.05.06

  Reported2021.05.16

  Abbott Trading (Shanghai) fined over infant formula batch[3]Abbott completed recovery of affected formula batch from the marketfinance.sina.com.cn

  Shanghai Municipal Administration for Market Regulation imposed an administrative penalty on Abbott Trading (Shanghai) over food allegedly contaminated by packaging materials or containers. The penalty included confiscation of items and illegal gains, and a fine of RMB 9,093,140.58.

• 2021.03.17

  Reported2021.03.17

  Fonterra and Abbott initiate sale of China joint-venture farm[5]恒天然与雅培启动出售中国合资牧场finance.sina.com.cn

  Fonterra said that, after discussions with joint-venture partner Abbott, the two parties decided to jointly initiate the sale of China joint-venture farm Chun Yuan Farm.

• 2021.01.13

  Reported2021.01.13

  45 maternity brands launch support service for new mothers[6]45家母婴品牌推出新手妈妈陪伴服务finance.sina.com.cn

  On January 13, 2021, 45 brands launched a support service for new mothers, including dedicated customer service that would listen to and chat with mothers. The brands also upgraded service to provide 15-day no-reason returns and priority logistics returns.

• 2020.04.28

  Reported2020.04.28

  Abbott changes distribution channels in China[7]雅培调整中国经销渠道finance.sina.com.cn

  Abbott notified Hangzhou Yitian and Shanghai Manbei that it would cancel some of their Abbott product distribution channels, with the affected business transferred to a new distributor. The changes were to take effect from April 1 and May 1, 2020, respectively; the article reports that the required three-party business transfer agreement had been signed.

• 2020.01.23

  Reported2020.01.23

  Abbott reports 2019 fourth-quarter and full-year results[8]雅培公布2019年第四季度及全年业绩finance.sina.com.cn

  Abbott reported fourth-quarter 2019 global sales of $8.3 billion, up 8.5% year over year, and full-year global sales of $32 billion, up 7.7%. It also provided a 2020 sales growth forecast of 7% to 8% and adjusted diluted earnings-per-share guidance of $3.55 to $3.65.

Read more

1. 1Abbott China initiates a voluntary recall of infant nutrition productsworkercn.cn
2. 2Abbott trading company fined over infant formula quality issuefinance.sina.com.cn
3. 3Abbott completed recovery of affected formula batch from the marketfinance.sina.com.cn
4. 4雅培计划分拆营养业务cfi.net.cn
5. 5恒天然与雅培启动出售中国合资牧场finance.sina.com.cn
6. 645家母婴品牌推出新手妈妈陪伴服务finance.sina.com.cn
7. 7雅培调整中国经销渠道finance.sina.com.cn
8. 8雅培公布2019年第四季度及全年业绩finance.sina.com.cn
9. 9雅培回应奶粉检出香兰素被罚909万：致歉并回收产品finance.qianlong.com
10. 10雅培回应奶粉香兰素超标被罚909万：已召回 对婴幼儿健康无危害f.sdnews.com.cn
11. 11雅培拟分拆营养业务，婴配粉要在中国市场“重头再来”吗？finance.china.com